Arkolith/Insider Trading/ETTX/Form 4

Ronsheim Matthew

Chief of Pharma Sciences & MFGEntasis Therapeutics Holdings Inc. (ETTX) · full profile →Form 4 · filed Jul 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2022Disposed to issuer(D)150K——0
Jul 7, 2022Tender(U)18K$2.20$39K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 11, 2022Other(J)20K—$00
Jul 11, 2022Other(J)15K—$00
Jul 11, 2022Other(J)33K—$00
Jul 11, 2022Other(J)20K—$00

Transaction Codes

D
Disposition to the issuer
U
See SEC Form 4 code table
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-078801) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML